Can anyone give a recent reference for the potential interaction between TCN and Birth control pills. This antibiotic seems to be the only medicine stopping my patient's acne after all other orals and topicals and accutane. Martin H. Kay Ph.D.,M.D. ------------------------ Medications associated with a possible risk of contraceptive failure: With the IUD: azathioprine (Zerner J, Doil KL, Drewry J, Leeber DA, Intrauterine contraceptive device failures in renal transplant patients. J Reprod Med 1981 Feb;26(2):99-102.) nonsteroidal anti-inflammatory agents (Papiernik E,Rozenbaum H, Amblard P, Dephot N, de Mouzon J, Intra-uterine device failure: relation with drug use. Eur J Obstet Gynecol Reprod Biol 1989 Sep;32(3):205-12) With the oral contraceptive failure has been questionable associated hepatic enzyme inducers (griseofulvin and rifampin) may increase metabolism of estrogen due to induction of hepatic microsomal enzymes. (USP-DI. Drug information for the health care professional, Vol 1. Taunton, Mass: Rand McNalley, 1995, pp. 1258,66.) penicillin and ampicillin may stimulate estrogen metabolism or reduce enterohepatic circulation of estrogens.(USPDI) tetracyclines, sulfonamides and tranquilizers may increase breakthrough bleeding and reduce contraceptive effectiveness. (USPDI.) itraconazole -case report of pregnancy occurring with use. (Pillans PI, Sparrow MJ. Pregnancy associated with a combined oral contraceptive and itraconazole [letter}. New Z Med J 1993:106:436.) Barbara R. Reed, MD ------------------- Be very careful about accepting at least some of these references at face value. All contraceptives fail even under ideal circumstances, lots of people take drugs, and it's awfully easy to make an association which may be spurious seem believable. It's been a while since I actually read the source literature, but at least for TCN and ampicillin in 1991, it's incredibly weak evidence. Mark Ling, M.D., Ph.D. ---------------------- There is an interesting letter from doctors Morgan & Carmichael to the editor of the Journal of Dermatologic Treatment, Vol. 6(4):250; Dec.1995. They review the theoretical mechanism of antibiotic-induced OC failure: decreased enterohepatic recirculation of estrogen due to inhibition of gut flora, e. g. by Tetracycline. They point out that this effect is only likely to occur during the first 2 weeks of tetracycline therapy, since the gut flora rapidly acquire resistance to it. They further report that statistics gathered by the UK Committee on Safety of Medicines since 1987 lead to the conclusion that the incidence of pregnancies in women on combined antibiotic/OC therapy is no greater than the intrinsic failure rate of OC's alone. Their suggestion is to instruct patients to use a barrier method of contraception during their first two weeks on tetracycline, and then carry on as usual. Gene Sienkiewicz, M. D. ----------------------- I am in agreement with Mark Ling about the weak association between oral contraceptive (OC) failure and drug usage. OCs have an intrinsic failure rate, which is argued but usually estimated to be less than one per cent. That is under ideal conditions. When faiure occurs and the woman was taking another drug, especially one which has had an association, however weak, with OC failure, it is the other drug and not the intrinsic failure rate of the OC which will be blamed. That is human nature, not science. Science is tough to come by under these circumstances. It was in this spirit that these references were offered--this spirit and the one that wants to know what an attorney might find that I wish I had known earlier. Barbara R. Reed, MD -------------------- Best one I think is Am J Ob & Gyn 164;1991: 28-33 where women were given tetracycline 500 mg qid (!) and there was NO change in plasma ethinyl estradiol or norethindrone levels. This is the only article I know of where there was scientific experimentation (instead of idle speculation, anecdotes and medico-legal mumbo-jumbo). The fact remains that certain other antibiotics (notably rifampin, and perhaps also ampicillin and TMP/SMX) which can interfere with the effectiveness of BCP. Kevin C. Smith MD FRCPC -----------------------